Clinical Trial Update: Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating DN-101 (calcitriol) in combination with docetaxel in patients previously enrolled in DN101-002 or DN101-004; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Prostate Cancer

Drugs mentioned

• DN-101
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Novacea | Conditions: Androgen Independent Prostate Cancer (AIPC), Non Small Cell Lung Cancer (NSCLC) | Phase 2 | Status: UNKNOWN